These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19659956)

  • 1. High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage.
    Hardie A; Moore C; Patnick J; Cuschieri K; Graham C; Beadling C; Ellis K; Frew V; Cubie HA
    Cytopathology; 2009 Aug; 20(4):235-41. PubMed ID: 19659956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test.
    Dixon EP; Lenz KL; Doobay H; Brown CA; Malinowski DP; Fischer TJ
    J Clin Virol; 2010 May; 48(1):31-5. PubMed ID: 20233675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay.
    Jamison J; Wilson RT; Carson J
    Cytopathology; 2009 Aug; 20(4):242-8. PubMed ID: 19291176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
    Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
    J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay.
    Weynand B; Delvenne P; Polet R; Guiot Y; Arafa M; Somja J; Galant C
    Clin Microbiol Infect; 2010 Jun; 16(6):671-5. PubMed ID: 19689463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation.
    Kuebler DL; Illingworth A; Blenc AM; Wilbur DC
    Cancer; 2007 Oct; 111(5):339-43. PubMed ID: 17879373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
    Getman D; Aiyer A; Dockter J; Giachetti C; Zhang F; Ginocchio CC
    J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform.
    Eder PS; Lou J; Huff J; Macioszek J
    J Clin Virol; 2009 Jul; 45 Suppl 1():S85-92. PubMed ID: 19651374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automation of the linear array HPV genotyping test and its application for routine typing of human papillomaviruses in cervical specimens of women without cytological abnormalities in Switzerland.
    Dobec M; Bannwart F; Kaeppeli F; Cassinotti P
    J Clin Virol; 2009 May; 45(1):23-7. PubMed ID: 19375383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay.
    Ermel A; Qadadri B; Morishita A; Miyagawa I; Yamazaki G; Weaver B; Tu W; Tong Y; Randolph M; Cramer H; Brown D
    J Virol Methods; 2010 Oct; 169(1):154-61. PubMed ID: 20670658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of RNA from residual BD SurePath liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTectt HPV-Proofer assay.
    Dixon EP; King LM; Adams MD; Grønn P; Murphy PG; Brown CA; Brough GH; Skomedal H; Malinowski DP; Fischer TJ
    J Virol Methods; 2008 Dec; 154(1-2):220-2. PubMed ID: 18761379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical performance of RNA isolated from BD SurePath™ cervical cytology specimens by the PreTect™ HPV-Proofer assay.
    Dixon EP; Grønn P; King LM; Passineau H; Doobay H; Skomedal H; Hariri J; Hay SN; Brown CA; Fischer TJ; Malinowski DP
    J Virol Methods; 2012 Nov; 185(2):199-203. PubMed ID: 22820075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
    van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
    J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of AMPLICOR HPV PCR and Linear Array assays on SurePath liquid-based Pap samples for the detection of high-risk HPV genotypes.
    Chernesky M; Jang D; Portillo E; Smieja M; Chong S; Buracond S; Klingel M; El Sebai R; Kapala J; Patel J; Biers K; Harroun N; Doucette C; Sumner J
    J Clin Virol; 2011 Mar; 50(3):201-4. PubMed ID: 21195020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of RNA from cell lines and cervical cytology specimens stored in BD SurePath preservative fluid and downstream detection of housekeeping gene and HPV E6 expression using real time RT-PCR.
    Murphy PG; Henderson DT; Adams MD; Horlick EA; Dixon EP; King LM; Avissar PL; Brown CA; Fischer TJ; Malinowski DP
    J Virol Methods; 2009 Mar; 156(1-2):138-44. PubMed ID: 19095009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
    Zhao FH; Hu SY; Bian JJ; Liu B; Peck RB; Bao YP; Pan QJ; Frappart L; Sellors J; Qiao YL
    Cancer Cytopathol; 2011 Dec; 119(6):387-94. PubMed ID: 21774094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential applications of oral brush cytology with liquid-based technology: results from a cohort of normal oral mucosa.
    Kujan O; Desai M; Sargent A; Bailey A; Turner A; Sloan P
    Oral Oncol; 2006 Sep; 42(8):810-8. PubMed ID: 16458571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the PapilloCheck® assay with the digene HC2 HPV DNA assay for the detection of 13 high-risk human papillomaviruses in cervical and anal scrapes.
    Didelot MN; Boulle N; Damay A; Costes V; Segondy M
    J Med Virol; 2011 Aug; 83(8):1377-82. PubMed ID: 21678441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.